A detailed history of Amalgamated Bank transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Amalgamated Bank holds 3,326 shares of APLT stock, worth $2,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,326
Previous 3,326 -0.0%
Holding current value
$2,128
Previous $16,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.04 - $6.37 $13,437 - $21,186
3,326 New
3,326 $16,000
Q2 2022

Aug 15, 2022

SELL
$0.76 - $2.64 $2,149 - $7,465
-2,828 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$1.48 - $6.22 $4,185 - $17,590
2,828 New
2,828 $6,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $30.7M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.